Benzinga | Jul 29, 2020 05:03PM EDT

Taro Pharmaceutical Indus Q1 Sales $117.60M Miss $158.35M Estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly sales of $117.60 million which missed the analyst consensus estimate of $158.35 million by 25.73 percent. This is a 27.09 percent decrease over sales of $161.30 million the same period last year.